EichorEICHOR
Condition: Resistant Pneumonia Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Resistant Pneumonia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Pat
Phase N/A · 1 location(s) · TTY Biopharm · NCT06966284Non-Invasive Interventions for Respiratory Recovery in Chronic Spinal Cord Injury
NA · 1 location(s) · Thomas Jefferson University · NCT07135583Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infecti
Phase 3 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07089186Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients W
Phase 3 · 1 location(s) · BioVersys SAS · NCT07326540Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae I
NA · 15 location(s) · Southeast University, China · NCT06051513Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE
Phase N/A · 2 location(s) · Sir Run Run Shaw Hospital · NCT07268560A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bact
NA · 1 location(s) · Henan University of Traditional Chinese Medicine · NCT07206745Peginterferon α-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus Pneumonia
NA · 2 location(s) · West China Second University Hospital · NCT06881056EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
Phase 4 · 4 location(s) · National University of Singapore · NCT05979545Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
NA · 2 location(s) · Stanford University · NCT05833217NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT05017766Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients
Phase N/A · 1 location(s) · Centre Hospitalier de Saint-Denis · NCT07052604Optimising TREATment for Severe Gram-Negative Bacterial Infections
Phase 4 · 41 location(s) · National University of Singapore · NCT07004049Fecal Microbiota Transplantation in Patients With Multiple Drug Resistant Klebsiella Pneumoniae Pneumonia
NA · 1 location(s) · luxia Kong · NCT06641778Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumo
Phase N/A · 1 location(s) · Fujian Medical University Union Hospital · NCT07086391Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases a
Phase N/A · 10 location(s) · Pneumonia Research Network on Genetic Resistance and Suscept · NCT05688774UTSW NORC Pilot Spinal Cord Injury Dietary Program
NA · 1 location(s) · University of Texas Southwestern Medical Center · NCT06924177Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients
Phase N/A · 1 location(s) · Shanghai General Hospital, China · NCT06566898Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
Phase 4 · 3 location(s) · Rambam Health Care Campus · NCT05922124Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05903352Dynamic Airway Resistance & ML: Guide Sputum Suction in Ventilated Patients
NA · 3 location(s) · Affiliated Hospital of Nantong University · NCT07375667Sulbactam-Durlobactam in CRAB Infection: A Real-World Cohort Study
Phase N/A · 1 location(s) · Sichuan Provincial People's Hospital · NCT07601711
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.